Glipizide

• 

  Subject Areas on Research

  • Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus. 
  • Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group. 
  • Glipizide stimulates sympathetic outflow in diabetes-prone mice. 
  • Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide. 
  • Long-term safety and efficacy of glipizide. 
  • Mechanism of action of the second-generation sulfonylurea glipizide. 
  • Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs. 
  • Sulfonylurea treatment of insulin-independent diabetes mellitus. 
  • Sulphonylureas increase the number of insulin receptors. 
  • Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.